Analysis of mutations in primary and metastatic synovial sarcoma

• Published in: Oncotarget Vol. 9; no. 96; pp. 36878 - 36888
• Main Authors: Xing, Zhuo, Wei, Lei, Jiang, Xiaoling, Conroy, Jeffrey, Glenn, Sean, Bshara, Wiam, Yu, Tao, Pao, Annie, Tanaka, Shinya, Kawai, Akira, Choi, Christopher, Wang, Jianmin, Liu, Song, Morrison, Carl, Yu, Y Eugene
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 07.12.2018
• Subjects: Research Paper; ADAM 17; synovial sarcoma; metastasis; SS18-SSX; whole exome sequencing
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.26416

Synovial sarcoma is the most common pediatric non-rhabdomyosarcoma soft tissue sarcoma and accounts for about 8-10% of all soft tissue sarcoma in childhood and adolescence. The presence of a chromosomal translocation-associated -fusion gene is causally linked to development of primary synovial sarcoma. Metastases occur in approximately 50-70% of synovial sarcoma cases with yet unknown mechanisms, which led to about 70-80% mortality rate in five years. To explore the possibilities to investigate metastatic mechanisms of synovial sarcoma, we carried out the first genome-wide search for potential genetic biomarkers and drivers associated with metastasis by comparative mutational profiling of 18 synovial sarcoma samples isolated from four patients carrying the primary tumors and another four patients carrying the metastatic tumors through whole exome sequencing. Selected from the candidates yielded from this effort, we examined the effect of the multiple missense mutations of ADAM17, which were identified solely in metastatic synovial sarcoma. The mutant alleles as well as the wild-type control were expressed in the mammalian cells harboring the - fusion gene. The ADAM17-P729H mutation was shown to enhance cell migration, a phenotype associated with metastasis. Therefore, like ADAM17-P729H, other mutations we identified solely in metastatic synovial sarcoma may also have the potential to serve as an entry point for unraveling the metastatic mechanisms of synovial sarcoma.